Nahdi Medical Company (4164.SR)
SAR 120.8
(0.0%)
SAR 120.8
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.36 Billion | 1.66 Billion | 1.33 Billion | 1.58 Billion | 1.34 Billion | 979.97 Million |
| Net Income | 944.24 Million | 937.92 Million | 857.26 Million | 849.11 Million | 692 Million | 610.65 Million |
| Depreciation & Amortization | 618.08 Million | 596.64 Million | 571.5 Million | 518.12 Million | 495.32 Million | 143.04 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -155.03 Million | 52.49 Million | -13.4 Million | -37.79 Million | -31.19 Million | 96.85 Million |
| Other non-cash items | -38.56 Million | 80.81 Million | -81.39 Million | 1.49 Billion | 1.18 Billion | 358.25 Million |
| Investing Cash Flow | -384.25 Million | -275.12 Million | -299.36 Million | -103.14 Million | -230.7 Million | -383.37 Million |
| Investments in PPE | -384.51 Million | -275.23 Million | -306.46 Million | -319.79 Million | -234.41 Million | -183.01 Million |
| Acquisitions | 254.01 Thousand | 103.28 Thousand | 7.1 Million | 13.82 Million | 6.18 Million | - |
| Investment purchases | - | - | - | -192.7 Million | -2.47 Million | -200.35 Million |
| Sales/Maturities of investments | - | - | - | 202.83 Million | 12.73 Million | - |
| Other Investing Activities | -30.39 Million | -24.86 Million | -16.79 Million | 192.7 Million | -12.73 Million | -220.87 Million |
| Financing Cash Flow | -1.15 Billion | -717.26 Million | -1.64 Billion | -846.52 Million | -915.08 Million | -550 Million |
| Debt repayment | -435.67 Million | -416.96 Million | -382.06 Million | -311.52 Million | -415.08 Million | - |
| Dividends payments | -715 Million | -300.3 Million | -1.26 Billion | -535 Million | -500 Million | -550 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -435.67 Million | -416.96 Million | -382.06 Million | -311.52 Million | -415.08 Million | - |
| Accounts receivables | -38.15 Million | 6.89 Million | -47.65 Million | 58.64 Million | -58.22 Million | 1.96 Million |
| Accounts payables | 257.14 Million | 153.17 Million | 43.73 Million | -70.24 Million | 84.47 Million | 5.66 Million |
| Inventory | -214.62 Million | -127.01 Million | 85.85 Million | -189.42 Million | -33.13 Million | 49.61 Million |
| Other working capital | -159.39 Million | 19.44 Million | -95.33 Million | 163.23 Million | -24.3 Million | 39.61 Million |
| Cash at beginning of period | 1.07 Billion | 401.04 Million | 1 Billion | 372.35 Million | 170.07 Million | 121.23 Million |
| Cash at end of period | 909.66 Million | 1.07 Billion | 401.04 Million | 1 Billion | 372.35 Million | 170.07 Million |
| Capital Expenditure | -384.51 Million | -275.23 Million | -306.46 Million | -319.79 Million | -234.41 Million | -183.01 Million |
| Effect of forex changes on cash | -447.82 Thousand | -210.16 Thousand | -23.52 Thousand | - | - | - |
| Net cash flow / Change in cash | -166.64 Million | 675.26 Million | -607.48 Million | 636.17 Million | 202.28 Million | 48.83 Million |
| Free Cash Flow | 984.21 Million | 1.39 Billion | 1.02 Billion | 1.26 Billion | 1.11 Billion | 796.95 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 260.6 Million | 232.94 Million | 944.24 Million | 182.6 Million | 222.6 Million | 276.7 Million |
| Depreciation & Amortization | 175.13 Million | 161.97 Million | 618.08 Million | 158.97 Million | 152.57 Million | 149.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -301.65 Million | 56.95 Million | -155.03 Million | -149.72 Million | 189.53 Million | -372.91 Million |
| Other non-cash items | 46.09 Million | 224.62 Million | -38.56 Million | 26.88 Million | -14.39 Million | -66.03 Million |
| Investing Cash Flow | -89.32 Million | -100.56 Million | -384.25 Million | -128.28 Million | -105.54 Million | -75.07 Million |
| Investments in PPE | -90.46 Million | -100.81 Million | -384.51 Million | -128.4 Million | -105.68 Million | -75.07 Million |
| Acquisitions | 1.14 Million | 254.01 Thousand | 254.01 Thousand | 120.53 Thousand | 133.47 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -11.61 Million | -9.85 Million | -30.39 Million | -8.09 Million | -9.24 Million | -5.91 Million |
| Financing Cash Flow | -59.34 Million | -502.36 Million | -1.15 Billion | -96.4 Million | -414.12 Million | -540.55 Million |
| Debt repayment | -58.23 Million | -113.47 Million | -435.67 Million | -96.4 Million | -89.12 Million | -150.55 Million |
| Dividends payments | -1.1 Million | -388.89 Million | -715 Million | - | -325 Million | -390 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -58.23 Million | - | -435.67 Million | -96.4 Million | -89.12 Million | -540.55 Million |
| Accounts receivables | -75.13 Million | -43.5 Million | -38.15 Million | -34.51 Million | 102.69 Million | -92.46 Million |
| Accounts payables | -195.39 Million | 505.47 Million | 257.14 Million | 10.96 Million | -646.96 Thousand | -236.21 Million |
| Inventory | 49.12 Million | -352.09 Million | -214.62 Million | -86.91 Million | 84.47 Million | -8.28 Million |
| Other working capital | -80.26 Million | -52.92 Million | -159.39 Million | -39.25 Million | 3.01 Million | -35.94 Million |
| Cash at beginning of period | 769.93 Million | 909.66 Million | 1.07 Billion | 916.44 Million | 885.79 Million | 1.51 Billion |
| Cash at end of period | 728.4 Million | 769.93 Million | 909.66 Million | 909.66 Million | 916.44 Million | 885.79 Million |
| Capital Expenditure | -90.46 Million | -100.81 Million | -384.51 Million | -128.4 Million | -105.68 Million | -75.07 Million |
| Effect of forex changes on cash | 42.28 Thousand | 777.07 Thousand | -447.82 Thousand | -827.54 Thousand | 2120.00 | -18.34 Thousand |
| Net cash flow / Change in cash | -41.53 Million | -139.72 Million | -166.64 Million | -6.78 Million | 30.65 Million | -628.7 Million |
| Free Cash Flow | 16.62 Million | 361.6 Million | 984.21 Million | 90.32 Million | 444.64 Million | -88.12 Million |
4375
ALTG-PA
GNGBY
BLSP
MLS
0R4Y